Dr. Yeqing Dong is an Assistant Researcher and Master’s Supervisor at the Tianjin Anding Hospital (Mental Health Center of Tianjin Medical University). She earned her Ph.D. from Peking Union Medical College. Her research primarily focuses on the early identification and pathogenic mechanisms of cognitive impairment in schizophrenia, with a strong emphasis on metabolomics and psychopharmacology. By integrating multi-omics approaches—including metabolomics, transcriptomics, and exosomal profiling—she aims to discover novel biomarkers and therapeutic targets. Dr. Dong has published over 20 SCI-indexed papers, including recent first-author works in *Schizophrenia Bulletin* and *Psychoneuroendocrinology*. She currently serves as the Principal Investigator for multiple grants, including the National Natural Science Foundation of China.